Skip to main content
Clinical Trials/NL-OMON43910
NL-OMON43910RecruitingNot Applicable

Fusion of Cardiac Computed Tomography Angiography (CTA) and 18F-Fluorodesoxyglucose Positron Emission Tomography (FDG-PET) to Determine Normal Peri-annular FDG Uptake after Aortic Valve Implantation - PROSPECTA

niversitair Medisch Centrum Utrecht0 sites75 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
75

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational invasive

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • - age > 50 years
  • - patients after uncomplicated PHV implantation
  • - Normal routine follow-up TTE
  • - 5 weeks or 12 weeks or 12 months after PHV implantation
  • - weight < 110 kg

Exclusion Criteria

  • - Known contrast allergy
  • - Known renal impairment (GFR<60)
  • - Other contraindications for contrast use according the standard daily clinical routine
  • - Use of pericardial patches and re-operation of aortic PHV in past medical history
  • - Contraindication for Computed Tomography Angiography according the standard daily clinical routine

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials

Fusion of Cardiac Computed Tomography... | Clinical Trial